IDiyas

For the Inventor, By the Inventor

Schildow, Germany

Thorsten Blume

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 94(Granted Patents)


Location History:

  • Berlin, DE (2002 - 2005)
  • Schildow, DE (2005 - 2010)
  • Wuppertal, DE (2017)

Company Filing History:

goldMedal9 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal2 out of 1,777 
 
Novo Nordisk A/s
 patents
bronzeMedal1 out of 378 
 
Bayer Pharma Aktiengesellschaft
 patents
4. 1 out of 192 
 
Bayer Schering Pharma Ag
 patents
5. 1 out of 1 
 
Novo Nordisk D/s
 patent
6. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2017

Loading Chart...
Loading Chart...
12 patents (USPTO):
1. 9708311 - Benzimidazole derivatives as EP4 antagonists (2017-07-18),
2. 7683081 - 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives (2010-03-23),
3. RE39678 - Meiosis regulating compounds (2007-06-04),
4. 7196202 - 1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives (2007-03-27),
5. 6962932 - 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives (2005-11-08),
6. 6946466 - Aromatic sulfonamides as peroxynitrite-rearrangement catalysts (2005-09-20),
7. 6916921 - Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds (2005-07-12),
8. 6903126 - 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives (2005-06-07),
9. 6884796 - Meiosis regulating compounds (2005-04-26),
10. 6855714 - 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives (2005-02-15),
11. 6683197 - Process for the production of 4,4-dimethyl-5&agr;-cholesta-8,14,24-trien-3&bgr;-01 and intermediate products in process (I) (2004-01-27),
12. 6407086 - Meiosis regulating compounds (2002-06-18),

Title: The Innovative Contributions of Thorsten Blume

Introduction

Thorsten Blume is a notable inventor based in Schildow, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzimidazole derivatives. With a total of 12 patents to his name, Blume's inventions have the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents, Blume has developed novel benzimidazole derivatives that act as EP4 antagonists. These compounds are designed for the production of pharmaceutical compositions aimed at treating diseases associated with the EP4 receptor. Additionally, he has created 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, which are intended for use in pharmaceutical agents targeting microglia activation and T-cell-mediated immunological diseases.

Career Highlights

Throughout his career, Thorsten Blume has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Blume has collaborated with notable colleagues such as Joachim Kuhnke and Wolfgang Halfbrodt. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Thorsten Blume's work in developing benzimidazole derivatives showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact on the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…